Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
NSAIDS	O
(Non-Steroidal	O
Anti-Inflammatory	O
Drug)	O
/	O
Penicillins	O
/	O
aspirin	O
/	O
eszopiclone	O
/	O
Hydrocortone	O
/	O
oxycodone	O
/	O
meperidine	O
/	O
omeprazole	O
/	O
gemfibrozil	O
/	O
propoxyphene	O
/	O
ranitidine	O
/	O
ibuprofen	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Flank	O
Pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
PCN	O
placement	O
___	O
TEE/cardioversion	O
___	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
female	O
with	O
past	O
medical	O
history	O
significant	O
for	O
CAD,	O
hypertension,	O
hyperlipidemia,	O
partial	O
colectomy	O
for	O
diverticulitis,	O
multiple	O
allergies	O
including	O
penicillins	O
and	O
CT	O
contrast,	O
who	O
developed	O
worsening	O
L	O
flank	O
pain	O
and	O
n/v	O
and	O
found	O
to	O
have	O
urosepsis	B-Urinary_tract_infection
from	O
obstructing	O
L	O
ureteral	O
stone	O
now	O
s/p	O
L	O
percutaneous	O
nephrostomy	O
tube	O
and	O
found	O
to	O
have	O
afib	O
with	O
RVR.	O
The	O
history	O
is	O
obtained	O
by	O
review	O
of	O
records	O
as	O
the	O
patient	O
is	O
unable	O
to	O
provide	O
history.	O
The	O
patient	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
2	O
days	O
ago	O
when	O
she	O
developed	O
abdominal	O
pain	O
as	O
well	O
as	O
an	O
ache	O
in	O
her	O
left	O
lower	O
abdomen.	O
She	O
then	O
developed	O
nausea	O
and	O
vomiting	O
on	O
day	O
of	O
presentation.	O
She	O
called	O
EMS	O
and	O
was	O
taken	O
to	O
___	O
in	O
___.	O
When	O
EMS	O
arrived	O
she	O
was	O
tachypneic	O
and	O
tachycardic	O
with	O
EKG	O
showing	O
atrial	O
fibrillation	O
with	O
RVR.	O
She	O
was	O
given	O
diltiazem	O
and	O
500cc	O
fluid.	O
On	O
arrival	O
to	O
the	O
OSH	O
ED	O
she	O
was	O
afeb,	O
BP	O
140/73,	O
P	O
___,	O
96%	O
RA.	O
Exam	O
was	O
notable	O
for	O
distress	O
secondary	O
to	O
pain	O
with	O
LLQ	O
tenderness,	O
b/l	O
___	O
edema.	O
Labs	O
were	O
notable	O
for	O
a	O
Cr	O
1.4,	O
WBC	O
12.5,	O
Hgb	O
11.0,	O
plt	O
235,	O
Trop	O
I	O
0.01,	O
ALT	O
48,	O
AST	O
38,	O
T	O
bili	O
1.2.	O
UA	O
with	O
___,	O
Nitrite,	O
glu,	O
bacteria.	O
CT	O
A/P	O
showed	O
moderate	O
hydronephrosis	O
of	O
the	O
left	O
kidney	O
with	O
a	O
proximal	O
ureteral	O
calculus	O
and	O
surrounding	O
inflammatory	O
changes.	O
A	O
CXR	O
showed	O
mild	O
CHF.	O
She	O
was	O
started	O
on	O
a	O
diltiazem	O
drip	O
at	O
10	O
mg/h	O
with	O
stable	O
blood	O
pressures	O
for	O
heart	O
rates	O
that	O
were	O
persisting	O
in	O
the	O
140s.	O
She	O
received	O
500	O
mg	O
of	O
IV	O
Levaquin	O
due	O
to	O
allergy	O
to	O
penicillin	O
and	O
was	O
transferred	O
to	O
___	O
for	O
evaluation	O
for	O
nephrostomy	O
placement.	O
In	O
the	O
___	O
ED,	O
at	O
___	O
initial	O
vitals	O
were	O
T	O
97.0,	O
HR	O
150,	O
BP	O
105/67,	O
RR	O
18,	O
SpO2	O
97%	O
RA.	O
Exam	O
notable	O
for	O
AAOx3,	B-Delirium
L	O
CVAT.	O
Labs	O
were	O
notable	O
for	O
WBC	O
25.5,	O
Hgb	O
10.1	O
without	O
prior	O
baseline,	O
Cr	O
1.3,	O
and	O
lactate	O
3.5.	O
UA	B-Urinary_tract_infection
again	O
demonstrated	O
concern	O
for	O
infection	B-Urinary_tract_infection
with	O
+blood,	O
+nitrite,	O
___.	O
Cultures	O
were	O
sent.	O
CT	O
abdomen	O
without	O
contrast	O
was	O
repeated	O
here	O
and	O
notable	O
for	O
obstructing	O
distal	O
left	O
ureteral	O
stone	O
measuring	O
up	O
to	O
7	O
mm,	O
as	O
well	O
as	O
collection	O
of	O
stones	O
in	O
the	O
L	O
renal	O
pelvis,	O
and	O
possible	O
evidence	O
of	O
calyceal	O
rupture.	O
She	O
was	O
continued	O
on	O
diltiazem	O
gtt	O
initially	O
but	O
became	O
hypotensive	O
with	O
pressures	O
in	O
___.	O
She	O
had	O
received	O
3L	O
IVF	O
at	O
OSH	O
and	O
1.5L	O
IVF	O
here,	O
for	O
a	O
total	O
of	O
4.5L.	O
Dilt	O
gtt	O
was	O
discontinued	O
and	O
she	O
was	O
started	O
on	O
Levophed	O
peripherally	O
at	O
0.08	O
mcg/kg/min	O
with	O
improvement	O
in	O
BPs.	O
Urology	O
was	O
consulted	O
and	O
recommended	O
stat	O
percutaneous	O
nephrostomy	O
tube.	O
She	O
was	O
taken	O
emergently	O
to	O
the	O
___	O
suite,	O
where	O
she	O
was	O
intubated	O
for	O
the	O
procedure	O
and	O
a	O
left	O
percutaneous	O
nephrostomy	O
tube	O
was	O
placed	O
uneventfully.	O
Intraoperatively	O
she	O
received	O
1	O
L	O
of	O
IV	O
fluid	O
as	O
well	O
as	O
5	O
mg	O
of	O
IV	O
to	O
help	O
metoprolol	O
and	O
esmolol	O
for	O
elevated	O
heart	O
rates	O
in	O
the	O
150s	O
which	O
improved	O
to	O
the	O
1	O
teens.	O
She	O
required	O
norepinephrine	O
at	O
0.1	O
and	O
phenylephrine	O
at	O
2.	O
Past	O
Medical	O
History:	O
Asthma	O
Coronary	O
artery	O
disease	O
Depression	O
Diabetes	O
Diverticulitis	O
Hyperlipidemia	O
Essential	O
tremor	O
GERD	O
Hiatal	O
hernia	O
Hyperlipidemia	O
Hypertension	O
Myocardial	O
infarction	O
Osteopenia	O
Peptic	O
ulcer	O
Social	O
History:	O
___	O
Family	O
History:	O
Cancer	O
in	O
her	O
mother	O
Stomach	O
cancer	O
in	O
her	O
father	O
___	O
in	O
her	O
maternal	O
grandmother	O
surgical	O
history:	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
========================	O
Vitals	O
reviewed	O
in	O
metavision	O
GEN:	O
Intubated	O
and	O
sedated,	O
at	O
time	O
of	O
exam	O
not	O
following	O
commands	O
but	O
previously	O
following	O
commands	O
when	O
off	O
sedation	O
EYES:	O
2mm	O
bilaterally,	O
reactive	O
to	O
light.	O
HENNT:	O
No	O
oral	O
lesions.	O
CV:	O
systolic	O
murmur,	O
irregular	O
tachycardic	O
rate	O
RESP:	O
rhonchorous	O
bilaterally,	O
good	O
air	O
movement	O
GI:	O
Soft,	O
nontender	O
on	O
exam	O
GU:	O
R	O
perc	O
nephrostomy	O
with	O
serosanguinous	O
drainage,	O
a	O
foley	O
is	O
draining	O
clear	O
urine	O
MSK:	O
2+	O
bilat	O
___	O
edema,	O
warm	O
SKIN:	O
tinea	O
pedis	O
bilaterally,	O
warm	O
NEURO:	O
Grossly	O
symmetric,	O
followed	O
commands	O
with	O
lightened	O
sedation,	O
but	O
with	O
sedation	O
on	O
she	O
is	O
not	O
moving	O
significantly	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
========================	O
VS:	O
24	O
HR	O
Data	O
(last	O
updated	O
___	O
@	O
733)	O
Temp:	O
98.5	O
(Tm	O
98.7),	O
BP:	O
108/67	O
(100-118/58-70),	O
HR:	O
61	O
(61-102),	O
RR:	O
20	O
(___),	O
O2	O
sat:	O
96%	O
(95-97),	O
O2	O
delivery:	O
RA	O
GEN:	O
in	O
no	O
acute	O
distress,	O
lying	O
in	O
bed,	O
awake	O
and	O
alert	O
HEENT:	O
sclerae	O
anicteric,	O
MMM	O
CARDIAC:	O
RRR,	O
nl	O
S1/S2,	O
no	O
m/g/r	O
LUNGS:	O
normal	O
work	O
of	O
breathing,	O
CTAB,	O
no	O
wheezing/crackles	O
ABD:	O
NABS,	O
soft,	O
nontender,	O
nondistended,	O
no	O
rebound/guarding,	O
L	O
PCN	O
in	O
place	O
with	O
dressing	O
c/d/i	O
EXTREMITIES:	O
wwp,	O
no	O
pitting	O
edema	O
SKIN:	O
warm,	O
dry,	O
no	O
notable	O
lesions	O
NEURO:	O
A/Ox3,	B-Delirium
moves	O
all	O
extremities	O
with	O
purpose	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
===============	O
___	O
04:22PM	O
BLOOD	O
WBC-25.5*	O
RBC-3.73*	O
Hgb-10.1*	O
Hct-34.2	O
MCV-92	O
MCH-27.1	O
MCHC-29.5*	O
RDW-16.7*	O
RDWSD-56.0*	O
Plt	O
___	O
___	O
04:22PM	O
BLOOD	O
___	O
PTT-24.2*	O
___	O
___	O
04:22PM	O
BLOOD	O
Glucose-201*	O
UreaN-20	O
Creat-1.3*	O
Na-142	O
K-4.7	O
Cl-107	O
HCO3-21*	O
AnGap-14	O
___	O
04:22PM	O
BLOOD	O
ALT-41*	O
AST-35	O
AlkPhos-121*	O
TotBili-0.9	O
DISCHARGE	O
LABS:	O
===============	O
___	O
06:12AM	O
BLOOD	O
WBC-12.8*	O
RBC-4.07	O
Hgb-10.8*	O
Hct-37.6	O
MCV-92	O
MCH-26.5	O
MCHC-28.7*	O
RDW-15.9*	O
RDWSD-54.0*	O
Plt	O
___	O
___	O
06:12AM	O
BLOOD	O
___	O
PTT-31.3	O
___	O
___	O
06:12AM	O
BLOOD	O
Glucose-166*	O
UreaN-28*	O
Creat-1.2*	O
Na-141	O
K-5.0	O
Cl-104	O
HCO3-22	O
AnGap-15	O
___	O
06:12AM	O
BLOOD	O
ALT-75*	O
AST-30	O
LD(LDH)-246	O
AlkPhos-176*	O
TotBili-0.5	O
___	O
06:12AM	O
BLOOD	O
Calcium-8.8	O
Phos-3.4	O
Mg-2.2	O
RELEVANT	O
IMAGING:	O
=================	O
CT	O
A/P	O
___	O
1.	O
Obstructing	O
distal	O
left	O
ureteral	O
stone	O
measuring	O
up	O
to	O
7	O
mm.	O
Left	O
perinephric	O
fluid	O
may	O
represent	O
forniceal	O
rupture.	O
2.	O
Cluster	O
of	O
nonobstructing	O
renal	O
stones	O
in	O
the	O
interpolar	O
region	O
of	O
the	O
left	O
kidney	O
measure	O
up	O
to	O
1.1	O
cm	O
in	O
greatest	O
dimension.	O
3.	O
Hepatomegaly	O
with	O
subtle	O
contour	O
nodularity	O
which	O
may	O
suggest	O
cirrhosis.	O
4.	O
Small	O
perihepatic	O
ascites	O
is	O
nonspecific.	O
5.	O
Minimal	O
anterolisthesis	O
of	O
L4	O
on	O
L5	O
of	O
indeterminate	O
chronicity,	O
likely	O
degenerative	O
in	O
etiology.	O
If	O
available,	O
comparison	O
with	O
prior	O
studies	O
is	O
recommended.	O
PERC	O
NEPHROSTO	O
___	O
FINDINGS:	O
1.	O
Left	O
mild	O
hydronephrosis.	O
2.	O
Minimal	O
urine	O
output.	O
IMPRESSION:	O
Successful	O
placement	O
of	O
8	O
___	O
nephrostomy	O
on	O
the	O
left.	O
ABDOMEN	O
(SUPINE	O
ONLY)	O
___	O
FINDINGS:	O
There	O
are	O
no	O
abnormally	O
dilated	O
loops	O
of	O
large	O
or	O
small	O
bowel.	O
There	O
is	O
no	O
free	O
intraperitoneal	O
air.	O
Osseous	O
structures	O
are	O
unremarkable.	O
Percutaneous	O
nephrostomy	O
catheter	O
overlies	O
the	O
expected	O
location	O
of	O
the	O
left	O
kidney.	O
Surgical	O
clips	O
are	O
noted.	O
IMPRESSION:	O
Percutaneous	O
nephrostomy	O
catheter	O
overlying	O
the	O
expected	O
location	O
of	O
the	O
left	O
kidney.	O
TTE	O
___	O
CONCLUSION:	O
The	O
left	O
atrial	O
volume	O
index	O
is	O
SEVERELY	O
increased.	O
The	O
right	O
atrium	O
is	O
moderately	O
enlarged.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
a	O
normal	O
cavity	O
size.	O
There	O
is	O
suboptimal	O
image	O
quality	O
to	O
assess	O
regional	O
left	O
ventricular	O
function.	O
No	O
thrombus	O
or	O
mass	O
is	O
seen	O
in	O
the	O
left	O
ventricle.	O
The	O
visually	O
estimated	O
left	O
ventricular	O
ejection	O
fraction	O
is	O
___.	O
Left	O
ventricular	O
cardiac	O
index	O
is	O
low	O
normal	O
(2.0-2.5	O
L/min/m2).	O
There	O
is	O
no	O
resting	O
left	O
ventricular	O
outflow	O
tract	O
gradient.	O
No	O
ventricular	O
septal	O
defect	O
is	O
seen.	O
Diastolic	O
parameters	O
are	O
indeterminate.	O
Normal	O
right	O
ventricular	O
cavity	O
size	O
with	O
SEVERE	O
global	O
free	O
wall	O
hypokinesis.	O
The	O
aortic	O
sinus	O
diameter	O
is	O
normal	O
for	O
gender	O
with	O
normal	O
ascending	O
aorta	O
diameter	O
for	O
gender.	O
The	O
aortic	O
arch	O
diameter	O
is	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
aortic	O
valve	O
stenosis.	O
There	O
is	O
no	O
aortic	O
regurgitation.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
with	O
no	O
mitral	O
valve	O
prolapse.	O
There	O
is	O
trivial	O
mitral	O
regurgitation.	O
The	O
tricuspid	O
valve	O
leaflets	O
appear	O
structurally	O
normal.	O
There	O
is	O
physiologic	O
tricuspid	O
regurgitation.	O
There	O
is	O
mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
a	O
trivial	O
pericardial	O
effusion.	O
IMPRESSION:	O
Suboptimal	O
image	O
quality.	O
Severely	O
depressed	O
biventricular	O
systolic	O
function.	O
No	O
clinically	O
significant	O
valvlular	O
regurgitation	O
or	O
stenosis.	O
Mild	O
pulmonary	O
hypertension.	O
DUPLEX	O
DOPP	O
ABD/PEL	O
___	O
FINDINGS:	O
Liver:	O
The	O
hepatic	O
parenchyma	O
is	O
diffusely	O
echogenic.	O
There	O
is	O
a	O
1	O
cm	O
cyst	O
in	O
the	O
left	O
hepatic	O
lobe.	O
No	O
suspicious	O
liver	O
lesions	O
are	O
identified.	O
There	O
is	O
trace	O
ascites.	O
Bile	O
ducts:	O
There	O
is	O
no	O
intrahepatic	O
biliary	O
ductal	O
dilation.	O
The	O
common	O
hepatic	O
duct	O
measures	O
6	O
mm.	O
Gallbladder:	O
The	O
gallbladder	O
appears	O
within	O
normal	O
limits,	O
without	O
stones,	O
abnormal	O
wall	O
thickening,	O
or	O
edema.	O
Pancreas:	O
The	O
imaged	O
portion	O
of	O
the	O
pancreas	O
appears	O
within	O
normal	O
limits,	O
with	O
portions	O
of	O
the	O
pancreatic	O
tail	O
obscured	O
by	O
overlying	O
bowel	O
gas.	O
Spleen:	O
The	O
spleen	O
demonstrates	O
normal	O
echotexture,	O
and	O
measures	O
9.4	O
cm.	O
Kidneys:	O
The	O
right	O
kidney	O
measures	O
9	O
cm.	O
No	O
hydronephrosis.	O
Doppler	O
evaluation:	O
The	O
main	O
portal	O
vein	O
is	O
patent,	O
with	O
flow	O
in	O
the	O
appropriate	O
direction.	O
Main	O
portal	O
vein	O
velocity	O
is	O
approximately	O
20	O
cm/sec.	O
Right	O
and	O
left	O
portal	O
veins	O
are	O
patent,	O
with	O
antegrade	O
flow.	O
The	O
main	O
hepatic	O
artery	O
is	O
patent	O
with	O
appropirate	O
waveform.	O
Right,	O
middle	O
and	O
left	O
hepatic	O
veins	O
are	O
patent,	O
with	O
appropriate	O
waveforms.	O
Splenic	O
vein	O
and	O
superior	O
mesenteric	O
vein	O
are	O
patent,	O
with	O
antegrade	O
flow.	O
IMPRESSION:	O
1.	O
Patent	O
hepatic	O
vasculature.	O
2.	O
Echogenic	O
liver	O
consistent	O
with	O
steatosis.	O
Other	O
forms	O
of	O
liver	O
disease	O
and	O
more	O
advanced	O
liver	O
disease	O
including	O
steatohepatitis	O
or	O
significant	O
hepatic	O
fibrosis/cirrhosis	O
cannot	O
be	O
excluded	O
on	O
this	O
study.	O
3.	O
Trace	O
ascites.	O
RECOMMENDATION(S):	O
Radiological	O
evidence	O
of	O
fatty	O
liver	O
does	O
not	O
exclude	O
cirrhosis	O
or	O
significant	O
liver	O
fibrosis	O
which	O
could	O
be	O
further	O
evaluated	O
by	O
___.	O
This	O
can	O
be	O
requested	O
via	O
the	O
Liver	O
Center	O
(FibroScan)	O
or	O
the	O
Radiology	O
Department	O
with	O
either	O
MR	O
___	O
or	O
US	O
___,	O
in	O
conjunction	O
with	O
a	O
GI/Hepatology	O
consultation"	O
*	O
CXR	O
___	O
The	O
right	O
internal	O
jugular	O
central	O
venous	O
catheter	O
terminates	O
in	O
the	O
superior	O
vena	O
cava.	O
There	O
are	O
low	O
lung	O
volumes.	O
Small	O
bilateral	O
pleural	O
effusions	O
are	O
unchanged.	O
Minimal	O
pulmonary	O
edema	O
is	O
unchanged.	O
There	O
is	O
no	O
focal	O
consolidation	O
or	O
pneumothorax.	O
The	O
cardiac	O
silhouette	O
remains	O
enlarged.	O
There	O
are	O
no	O
acute	O
osseous	O
abnormalities.	O
___	O
TTE	O
There	O
is	O
moderate	O
global	O
left	O
ventricular	O
hypokinesis.	O
Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
moderately	O
depressed.	O
Quantitative	O
biplane	O
left	O
ventricular	O
ejection	O
fraction	O
is	O
38	O
%.	O
The	O
right	O
ventricle	O
has	O
moderate	O
global	O
free	O
wall	O
hypokinesis.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
with	O
no	O
mitral	O
valve	O
prolapse.	O
There	O
is	O
mild	O
[1+]	O
mitral	O
regurgitation.	O
The	O
tricuspid	O
valve	O
leaflets	O
appear	O
structurally	O
normal.	O
There	O
is	O
mild	O
[1+]	O
tricuspid	O
regurgitation.	O
IMPRESSION:	O
Focused	O
study	O
regarding	O
LV	O
function.	O
Moderate	O
global	O
LV	O
systolic	O
dysfunction.	O
RV	O
appears	O
moderately	O
hypokinetic.	O
Mild	O
mitral	O
regurgitation.	O
Atrial	O
fibrillation	O
with	O
tachycardia.	O
Compared	O
with	O
the	O
prior	O
TTE	O
(images	O
reviewed)	O
of	O
___	O
LV	O
function	O
appears	O
more	O
vigorous	O
though	O
still	O
moderately	O
impaired.	O
No	O
apical	O
views	O
on	O
prior	O
for	O
side	O
by	O
side	O
comparison.	O
Rhythm	O
remains	O
atrial	O
fibrillation	O
with	O
tachycardia.	O
MICROBIOLOGY:	O
===============	O
___	O
BLOOD	O
CULTURE	O
No	O
growth	O
___	O
URINE	B-Urinary_tract_infection
ENTEROBACTER	O
CLOACAE	O
COMPLEX.	O
1,000	O
-	O
10,000	O
CFU/ML.	O
This	O
organism	O
may	O
develop	O
resistance	O
to	O
third	O
generation	O
cephalosporins	O
during	O
prolonged	O
therapy.	O
Therefore,	O
isolates	O
that	O
are	O
initially	O
susceptible	O
may	O
become	O
resistant	O
within	O
three	O
to	O
four	O
days	O
after	O
initiation	O
of	O
therapy.	O
For	O
serious	O
infections,	B-Urinary_tract_infection
repeat	O
culture	O
and	O
sensitivity	O
testing	O
may	O
therefore	O
be	O
warranted	O
if	O
third	O
generation	O
cephalosporins	O
were	O
used.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
ENTEROBACTER	O
CLOACAE	O
COMPLEX	O
|	O
CEFEPIME--------------	O
<=1	O
S	O
CEFTAZIDIME-----------	O
<=1	O
S	O
CEFTRIAXONE-----------	O
<=1	O
S	O
CIPROFLOXACIN---------<=0.25	O
S	O
GENTAMICIN------------	O
<=1	O
S	O
MEROPENEM-------------<=0.25	O
S	O
NITROFURANTOIN--------	O
<=16	O
S	O
PIPERACILLIN/TAZO-----	O
<=4	O
S	O
TOBRAMYCIN------------	O
<=1	O
S	O
TRIMETHOPRIM/SULFA----	O
<=1	O
S	O
ANAEROBIC	O
CULTURE	O
(Final	O
___:	O
NO	O
ANAEROBES	O
ISOLATED.	O
Brief	O
Hospital	O
Course:	O
SUMMARY:	O
=	O
=	O
=	O
=	O
=	O
=	O
=	O
=	O
================================================================	O
Ms.	O
___	O
is	O
a	O
___	O
year-old	O
woman	O
with	O
PMH	O
of	O
CAD,	O
HTN,	O
HLD,	O
Pt	O
Colectomy	O
for	O
diverticulitis	O
who	O
presented	O
with	O
flank	O
pain	O
and	O
N/V,	O
found	O
to	O
have	O
septic	O
shock	O
due	O
to	O
infected	B-Urinary_tract_infection
obstructing	O
L	O
ureteral	B-Urinary_tract_infection
stone	O
now	O
s/p	O
L	O
percutaneous	O
nephrostomy	O
tube,	O
with	O
course	O
complicated	O
by	O
A	O
fib	O
with	O
RVR,	O
s/p	O
cardioversion	O
to	O
NSR.	O
ACTIVE	O
ISSUES:	O
=	O
=	O
=	O
=	O
=	O
=	O
=	O
=	O
================================================================	O
#	O
Septic	B-Urinary_tract_infection
Shock,	O
___	O
Obstructing	O
L	O
Ureteral	B-Urinary_tract_infection
Stone	O
Presented	O
with	O
flank	O
pain,	O
found	O
to	O
have	O
L	O
hydronephrosis	O
and	O
L	O
ureteral	O
calculus.	O
Became	O
hypotensive	O
and	O
treated	O
with	O
IVF	O
then	O
started	O
on	O
pressors.	O
___	O
placed	O
stat	O
PCN	O
tube	O
and	O
she	O
was	O
admitted	O
to	O
MICU.	O
UCX	B-Urinary_tract_infection
grew	O
enterobacter,	O
treated	B-Urinary_tract_infection
with	B-Urinary_tract_infection
meropenem	B-Urinary_tract_infection
-->	O
Bactrim	O
for	O
total	O
10	O
day	O
course.	O
Weaned	O
off	O
pressors.	O
Plan	O
for	O
o/p	O
urology	O
&	O
___	O
f/u	O
for	O
consideration	O
of	O
stone	O
removal	O
and	O
PCN	O
tube	O
removal.	O
Discharged	O
with	O
L	O
PCN	O
in	O
place.	O
#	O
A	O
Fib	O
with	O
RVR	O
v.	O
A	O
Flutter	O
During	O
ED	O
went	O
into	O
A	O
fib	O
with	O
RVR.	O
First	O
started	O
on	O
diltiazem,	O
then	O
after	O
pressures	O
dropped	O
was	O
d/c'ed.	O
Attempted	O
metoprolol	O
&	O
esmolol	O
gtt	O
with	O
minimal	O
HR	O
control.	O
Transitioned	O
back	O
to	O
diltiazem	O
gtt	O
after	O
weaning	O
off	O
pressors,	O
which	O
was	O
tolerated	O
well,	O
then	O
transitioned	O
to	O
PO	O
diltiazem,	O
later	O
switched	O
to	O
metoprolol.	O
Started	O
on	O
heparin	O
gtt	O
for	O
AC	O
then	O
transitioned	O
to	O
Apixaban.	O
On	O
___	O
she	O
underwent	O
TEE	O
and	O
cardioversion	O
and	O
subsequently	O
remained	O
in	O
sinus	O
rhythm.	O
She	O
was	O
loaded	O
with	O
amiodarone	O
with	O
plan	O
to	O
follow	O
up	O
with	O
outpatient	O
Cardiology.	O
#	O
___	O
Reportedly	O
has	O
history	O
of	O
possible	O
CHF	O
although	O
no	O
echos	O
in	O
our	O
system	O
and	O
no	O
known	O
clear	O
diagnosis	O
of	O
CHF.	O
TTE	O
here	O
with	O
significantly	O
decreased	O
EF	O
to	O
___,	O
although	O
unclear	O
if	O
this	O
is	O
driven	O
by	O
sepsis	O
&/or	O
a	O
fib.	O
Treated	O
with	O
IV	O
Lasix	O
intermittently	O
for	O
preload	O
reduction.	O
Repeat	O
TTE	O
showed	O
slight	O
improvement	O
with	O
EF	O
38%.	O
She	O
will	O
follow	O
up	O
with	O
Cardiology	O
as	O
outpatient.	O
#	O
Shock	O
Liver	O
Developed	O
elevated	O
transaminases	O
in	O
hepatocellular	O
injury	O
pattern	O
around	O
time	O
of	O
presentation	O
with	O
septic	O
shock.	O
RUQUS	O
with	O
steatosis,	O
no	O
vascular	O
compromise.	O
Thought	O
most	O
likely	O
due	O
to	O
shock	O
liver;	O
resolved	O
with	O
time	O
and	O
improvement	O
in	O
hemodynamics.	O
#	O
___	O
Baseline	O
Cr	O
1.0.	O
Cr	O
elevated	O
to	O
peak	O
of	O
3.7.	O
Thought	O
to	O
be	O
prerenal	O
v.	O
ATN.	O
Treated	O
with	O
diuretics,	O
and	O
ultimately	O
began	O
urinating	O
on	O
her	O
own	O
and	O
Cr	O
improved	O
to	O
near	O
baseline.	O
CHRONIC	O
ISSUES:	O
=	O
=	O
=	O
=	O
=	O
=	O
=	O
=	O
================================================================	O
#	O
Anemia	O
Normocytic,	O
at	O
baseline	O
#	O
CAD	O
?History	O
of	O
CAD.	O
No	O
clear	O
records	O
to	O
distinguish	O
prior	O
MI/stents.	O
Allergic	O
to	O
ASA,	O
continued	O
atorvastatin.	O
#	O
DMT2	O
Held	O
oral	O
medications;	O
ISS.	O
TRANSITIONAL	O
ISSUES:	O
=	O
=	O
=	O
=	O
=	O
=	O
=	O
=	O
================================================================	O
[	O
]	O
New	O
diagnosis	O
of	O
HFrEF,	O
with	O
EF	O
improving	O
over	O
hospitalization	O
period.	O
Will	O
need	O
Cardiology	O
follow-up	O
and	O
further	O
work-up	O
including	O
repeat	O
TTE.	O
Should	O
consider	O
starting	O
diuresis	O
as	O
needed.	O
[	O
]	O
Abdominal	O
ultrasound	O
with	O
evidence	O
of	O
steatosis	O
and	O
trace	O
ascites,	O
will	O
need	O
further	O
work-up	O
for	O
possible	O
cirrhosis	O
(no	O
known	O
diagnosis)	O
[	O
]	O
New	O
diagnosis	O
of	O
atrial	O
fibrillation,	O
s/p	O
cardioversion.	O
Continued	O
on	O
metoprolol	O
as	O
well	O
as	O
amiodarone,	O
plan	O
to	O
eventually	O
discontinue	O
the	O
metoprolol	O
at	O
least	O
if	O
continues	O
in	O
NSR.	O
[	O
]	O
Discharged	O
on	O
Apixaban	O
for	O
AC,	O
can	O
be	O
eventually	O
discontinued	O
as	O
outpatient	O
if	O
remains	O
in	O
NSR	O
[	O
]	O
Discharged	O
on	O
home	O
metformin	O
and	O
glipizide,	O
but	O
did	O
have	O
HbA1c	O
9.2%	O
and	O
required	O
standing	O
insulin	O
during	O
admission.	O
Consider	O
further	O
titration	O
in	O
rehab	O
and	O
as	O
outpatient.	O
Note	O
patient	O
will	O
have	O
difficulty	O
with	O
self-administering	O
insulin	O
due	O
to	O
chronic	O
hand	O
tremor.	O
[	O
]	O
Foley	O
removed	O
on	O
day	O
of	O
discharge,	O
check	O
PVRs	O
to	O
ensure	O
not	O
retaining	O
[	O
]	O
Patient	O
noted	O
to	O
have	O
slightly	O
elevated	O
WBC	O
count	O
at	O
discharge	O
to	O
12.8.	O
Please	O
re-check	O
CBC	O
on	O
___	O
to	O
trend.	O
No	O
evidence	O
of	O
infection	O
on	O
exam.	O
[	O
]	O
Should	O
see	O
allergist	O
for	O
PCN	O
testing	O
to	O
clear	O
allergy	O
as	O
well	O
as	O
CT	O
contrast	O
testing	O
(as	O
tolerated	O
dye	O
for	O
nephrostomy	O
w/o	O
issue)	O
[	O
]	O
Needs	O
urology	O
&	O
___	O
f/u	O
as	O
outpatient	O
for	O
PCN	O
&	O
stone	O
removal	O
[	O
]	O
Non-immune	O
to	O
hepatitis	O
B	O
[	O
]	O
Consider	O
iron	O
repletion	O
as	O
outpatient	O
MEDICATION	O
CHANGES:	O
=	O
=	O
=	O
=	O
=	O
=	O
=	O
=	O
================================================================	O
-	O
Started	O
acetaminophen	O
for	O
pain	O
control	O
of	O
L	O
PCN	O
tube	O
-	O
Started	O
amiodarone	O
(loading	O
dose	O
400mg	O
Q8H	O
for	O
total	O
of	O
5g,	O
followed	O
by	O
200mg	O
QD)	O
--received	O
total	O
2.4g	O
amiodarone	O
in-house	O
prior	O
to	O
discharge	O
-	O
Started	O
Apixaban	O
5mg	O
BID	O
for	O
atrial	O
fibrillation	O
-	O
Started	O
metoprolol	O
succinate	O
XL	O
200mg	O
QD	O
for	O
atrial	O
fibrillation	O
-	O
Stopped	O
atenolol	O
50mg	O
daily	O
(replaced	O
by	O
metoprolol)	O
-	O
Stopped	O
losartan	O
100mg	O
daily	O
given	O
normotensive	O
with	O
metoprolol	O
alone	O
Discharge	O
weight:	O
84.7	O
kg	O
Discharge	O
Cr:	O
1.2	O
Discharge	O
Hb:	O
10.8	O
CODE	O
STATUS:	O
Full	O
code,	O
confirmed	O
CONTACT:	O
Daughter	O
___	O
___	O
___	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Albuterol	O
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q4H:PRN	O
wheezing	O
2.	O
Acetaminophen	O
w/Codeine	O
1	O
TAB	O
PO	O
Q8H:PRN	O
Pain	O
-	O
Moderate	O
3.	O
Latanoprost	O
0.005%	O
Ophth.	O
Soln.	O
1	O
DROP	O
BOTH	O
EYES	O
QHS	O
4.	O
MetFORMIN	O
(Glucophage)	O
1000	O
mg	O
PO	O
BID	O
5.	O
Atenolol	O
50	O
mg	O
PO	O
DAILY	O
6.	O
GlipiZIDE	O
15	O
mg	O
PO	O
DAILY	O
7.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
8.	O
Calcitrate	O
(calcium	O
citrate)	O
200	O
mg	O
(950	O
mg)	O
oral	O
DAILY	O
9.	O
LOPERamide	O
2	O
mg	O
PO	O
TID:PRN	O
diarrhea	O
10.	O
EPINEPHrine	O
(EpiPEN)	O
0.3	O
mg	O
IM	O
ONCE	O
MR1	O
allergic	O
reaction/anaphylaxis	O
11.	O
Losartan	O
Potassium	O
100	O
mg	O
PO	O
DAILY	O
12.	O
Nitroglycerin	O
SL	O
0.4	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild/Fever	O
2.	O
Amiodarone	O
400	O
mg	O
PO	O
Q8H	O
Duration:	O
7	O
Doses	O
After	O
7	O
doses,	O
transition	O
to	O
200mg	O
daily.	O
3.	O
Amiodarone	O
200	O
mg	O
PO	O
DAILY	O
Start	O
after	O
completion	O
of	O
loading	O
dose	O
(5g)	O
(should	O
be	O
on	O
___	O
4.	O
Apixaban	O
5	O
mg	O
PO	O
BID	O
5.	O
Metoprolol	O
Succinate	O
XL	O
200	O
mg	O
PO	O
DAILY	O
6.	O
Acetaminophen	O
w/Codeine	O
1	O
TAB	O
PO	O
Q8H:PRN	O
Pain	O
-	O
Moderate	O
7.	O
Albuterol	O
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q4H:PRN	O
wheezing	O
8.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
9.	O
Calcitrate	O
(calcium	O
citrate)	O
200	O
mg	O
(950	O
mg)	O
oral	O
DAILY	O
10.	O
EPINEPHrine	O
(EpiPEN)	O
0.3	O
mg	O
IM	O
ONCE	O
MR1	O
allergic	O
reaction/anaphylaxis	O
11.	O
GlipiZIDE	O
15	O
mg	O
PO	O
DAILY	O
12.	O
Latanoprost	O
0.005%	O
Ophth.	O
Soln.	O
1	O
DROP	O
BOTH	O
EYES	O
QHS	O
13.	O
LOPERamide	O
2	O
mg	O
PO	O
TID:PRN	O
diarrhea	O
14.	O
MetFORMIN	O
(Glucophage)	O
1000	O
mg	O
PO	O
BID	O
15.	O
Nitroglycerin	O
SL	O
0.4	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Urosepsis	B-Urinary_tract_infection
Ureteral	O
Stone	O
Atrial	O
Fibrillation	O
s/p	O
cardioversion	O
HFrEF	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Out	O
of	O
Bed	O
with	O
assistance	B-Bed_Chairbound
to	B-Bed_Chairbound
chair	B-Bed_Chairbound
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
privilege	O
caring	O
for	O
you	O
at	O
___.	O
WHY	O
WAS	O
I	O
IN	O
THE	O
HOSPITAL?	O
-	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
because	O
of	O
back	O
pain	O
and	O
you	O
were	O
found	O
to	O
have	O
a	O
stone	O
and	O
infection	B-Urinary_tract_infection
in	O
your	O
kidney.	B-Urinary_tract_infection
WHAT	O
HAPPENED	O
TO	O
ME	O
IN	O
THE	O
HOSPITAL?	O
-	O
A	O
tube	O
was	O
placed	O
in	O
your	O
kidney	O
to	O
help	O
urine	O
drain.	O
You	O
were	O
also	O
given	O
antibiotics.	O
-	O
You	O
developed	O
a	O
fast	O
heart	O
rate	O
known	O
as	O
'Atrial	O
Fibrillation',	O
which	O
was	O
shocked	O
back	O
into	O
a	O
normal	O
rhythm	O
-	O
Several	O
tests	O
were	O
done	O
and	O
you	O
were	O
found	O
to	O
have	O
heart	O
failure	O
-	O
You	O
were	O
started	O
on	O
some	O
new	O
medications,	O
refer	O
to	O
medication	O
list	O
WHAT	O
SHOULD	O
I	O
DO	O
AFTER	O
I	O
LEAVE	O
THE	O
HOSPITAL?	O
-	O
Please	O
continue	O
to	O
take	O
all	O
of	O
your	O
medications	O
and	O
follow-up	O
with	O
your	O
appointments	O
as	O
listed	O
below.	O
-	O
The	O
tube	O
draining	O
your	O
kidney	O
should	O
remain	O
in	O
place	O
until	O
you	O
see	O
the	O
Urologist.	O
-	O
Make	O
sure	O
you	O
have	O
appointments	O
with	O
the	O
Cardiologist	O
and	O
Urologist	O
as	O
well	O
as	O
your	O
primary	O
care	O
doctor.	O
We	O
wish	O
you	O
the	O
best!	O
Sincerely,	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

